Clinics · 2022 · 23 citations · 21 references
Veterinary MedicineCardiologyImmunologyEpidemiologyInflammationRisk Factor AnalysisCardiac BiomarkersCardiovascular DiseaseChronic InflammationHeart FailureInflammatory BiomarkersSystemic Inflammatory ResponseC-reactive Protein TestingHeart Failure EpidemiologyInflammation In Cardiovascular DiseaseInflammatory Cardiac BiomarkersPredictive Model PerformanceReceiver Operating Characteristic AnalysisSystemic Inflammation Markers
OBJECTIVE: As a greater proportion of patients survived their initial cardiac insult, Chronic Heart Failure (CHF) is becoming a major cause of worldwide morbidity and mortality. However, the mechanism underlying the inflammation in patients with CHF has not yet been elaborated. This study aims to explore the associations between inflammation and CHF patients, and the predictive performance of inflammatory indicators in identifying patients with CHF. METHODS: A matched case-control study was conducted by recruiting 385 patients who were diagnosed with CHF from January 2018 to December 2019 in The First Affiliated Hospital of Chongqing Medical University. Each CHF patient was matched against one control subject without CHF on the criteria of age, sex, Body Mass Index (BMI), smoking status, and comorbidities. The clinical data and systemic inflammatory indicators were compared between the two groups, independent risk factors of CHF were identified by multivariate regression analysis, and the predictive values of systemic inflammatory indicators for CHF were analyzed by Receiver Operating Characteristic (ROC) curve analysis. RESULTS: After processed in the univariate and multivariate regression analysis models, three systemic inflammatory indicators (hs-CRP [high sensitivity C Reactive Protein], LMR [lymphocyte-to-monocyte ratio], and Monocyte-to-High-density-lipoprotein Ratio [MHR]) were considered as independent predictors of CHF, among which the hs-CRP exhibited the best predictive performance (AUC = 0.752, 95%CI 0.717‒0.786, p < 0.001), followed by LMR (AUC = 0.711, 95% CI 0.675‒0.747, p < 0.001) and MHR (AUC = 0.673, 95% CI 0.635‒0.710, p < 0.001). The three-indicator combination showed an improved diagnostic performance (AUC = 0.757, 95% CI 0.724‒0.791, p < 0.001). In addition, the results of subgroup comparisons demonstrated that hs-CRP and MHR were associated with the severity of CHF (p < 0.001). CONCLUSIONS: The systemic inflammatory indicators such as hs-CRP, LMR, and MHR were independently correlated with the attack of CHF and might be the complementary markers of the diagnosis of CHF.
21
John G.F. Cleland, Andrew J.S. Coats, Ewa A. Jankowska et al. · PubMed · 2021 · 19.5K citations
Executive Summary: Heart Disease and Stroke Statistics—2010 Update
Donald M. Lloyd‐Jones, Robert J. Adams, Todd M. Brown et al. · Circulation · 2010 · 1.4K citations
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
Douglas L. Mann, John J.V. McMurray, Milton Packer et al. · Circulation · 2004 · 1.2K citations
Medicine, Cardiology, Pharmacology +15